India's cancer drug price reset draws scrutiny over impact on pharma companies and hospitals
New drug pricing rules in a major generics market could reshape margins for manufacturers and providers.
Read at Siliconindia →Full coverage · 3 outlets
- Siliconindia · lead
- STATPharmalittle: We're reading about India's new manufacturing rules, clinical trials in China, and more
- LinkedIn💊 Cancer drugs get cheaper: Govt caps trade margins on non-scheduled drugs at 30% 💰 Prices could fall up to 70%, saving patients around ₹2,500 crore a year ⚖️ Supreme Court hearing on drug mark-ups